Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Tislelizumab can cause cutaneous lupus erythematosus.

The CRABP I gene in cashmere goats is highly conserved but has unique features at specific amino sites.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

c-Kit is important for heart regeneration and cancer development.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Hydrophilic carbon dots cause one protein to clump more and prevent another from clumping.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Ruxolitinib can cause a delayed skin reaction on the nose.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.